News & Updates

A study shows an association between COVID-19 infection and an elevated risk of new-onset respiratory type 2 inflammatory diseases (T2IDs), while vaccination remains protective against such diseases.

Patients with long COVID may derive benefits from treatment with fluvoxamine, which has been shown to reduce fatigue and improve quality of life (QoL) in a study. The use of metformin, on the other hand, shows no significant advantage.

Post-exposure prophylaxis-in-pocket (PIP) appears as effective as pre-exposure prophylaxis (PrEP) in improving quality of life (QoL) of individuals at low risk for HIV but may be a less costly option, according to a matched-control study presented at CROI 2026.

Genetic markers, both in and outside the immune system, influence an individual’s response to the SARS-CoV-2 vaccine, and these effects are similar in patients with or without systemic autoimmune diseases (SADs), reports a study.

Patients with stage 5 chronic kidney disease (CKD5) are at greater risk of developing tuberculosis (TB) than the general population, especially if they are male or receiving dialysis, suggests a Singapore study.

Recurrent urinary tract infection (UTI) care in primary and secondary care settings appears to be characterized by low guideline adherence, with a substantial number of women still being treated with antibiotics and subjected to low-yield investigations, according to a study.